IO Biotech (IOBT) Institutional Ownership $1.04 +0.06 (+6.12%) As of 05/19/2025 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for IO Biotech (NASDAQ:IOBT)CurrentInstitutional OwnershipPercentage54.76%Number ofInstitutional Buyers(last 12 months)6TotalInstitutional Inflows(last 12 months)$1.47MNumber ofInstitutional Sellers(last 12 months)5TotalInstitutional Outflows(last 12 months)$2.25M Get IOBT Insider Trade Alerts Want to know when executives and insiders are buying or selling IO Biotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data IOBT Institutional Buying and Selling by Quarter IO Biotech Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/15/2025 Landscape Capital Management L.L.C.400,234$436K0.0%-9.5%0.608% 5/8/2025 XTX Topco Ltd50,486$55K0.0%+80.0%0.077% 5/7/2025 Dauntless Investment Group LLC681,446$743K0.9%-8.9%1.034% 2/17/2025 Bridgeway Capital Management LLC174,000$160K0.0%-12.8%0.264% 2/17/2025 Citadel Advisors LLC270,504$249K0.0%N/A0.411% 2/14/2025 Dauntless Investment Group LLC747,646$688K0.7%N/A1.135% 2/13/2025 XTX Topco Ltd28,040$26K0.0%N/A0.043% 2/13/2025 Renaissance Technologies LLC118,800$109K0.0%+22.5%0.180% 2/12/2025 Landscape Capital Management L.L.C.442,196$407K0.0%N/A0.671% 1/30/2025 Vontobel Holding Ltd.32,667$30K0.0%N/A0.050% Get the Latest News and Ratings for IOBT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for IO Biotech and its competitors with MarketBeat's FREE daily newsletter. 10/24/2024 Novo Holdings A S3,354,449$3.52M0.2%-24.3%5.092% 8/20/2024 Novo Holdings A S4,429,449$5.18M0.3%-12.9%6.723% 8/15/2024 Armistice Capital LLC1,545,000$1.81M0.0%-10.4%2.345% 8/12/2024 XTX Topco Ltd26,555$31K0.0%+67.4%0.040% 8/9/2024 Renaissance Technologies LLC180,800$212K0.0%+8.1%0.274% 2/15/2024 PFM Health Sciences LP2,341,107$4.40M0.3%+73.0%3.554% 2/13/2024 Stonepine Capital Management LLC1,666,037$3.13M1.4%-15.7%2.529% 2/13/2024 Armistice Capital LLC1,924,000$3.62M0.0%-10.4%2.920% 11/15/2023 Armistice Capital LLC2,148,000$3.03M0.0%N/A3.260% 11/14/2023 Stonepine Capital Management LLC1,975,308$2.79M0.9%N/A2.998% 11/14/2023 Pivotal bioVenture Partners Investment Advisor LLC864,197$1.22M0.5%N/A1.312% 11/8/2023 Vivo Capital LLC6,173,439$8.71M1.1%+104.7%9.371% 7/25/2023 Summit Trail Advisors LLC43,744$86K0.0%N/A0.152% 2/14/2023 RA Capital Management L.P.1,127,260$2.59M0.1%-39.3%3.911% 11/14/2022Psagot Value Holdings Ltd. Israel40,846$111K0.0%N/A0.142% 11/2/2022 Victory Capital Management Inc.43,741$119K0.0%N/A0.152% 2/15/2022 Samsara BioCapital LLC1,120,437$7.17M1.4%N/A3.888% 2/15/2022 Capital World Investors1,235,000$8.11M0.0%N/A4.286% 2/14/2022 Soleus Capital Management L.P.672,734$4.31M0.4%N/A2.335% 2/14/2022 Novo Holdings A S3,277,932$20.98M1.0%N/A11.376% (Data available from 1/1/2016 forward) IOBT Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of IOBT shares? During the previous two years, 15 institutional investors and hedge funds held shares of IO Biotech. The most heavily invested institutionals were Vivo Capital LLC ($8.71M), PFM Health Sciences LP ($4.40M), Novo Holdings A S ($3.52M), Stonepine Capital Management LLC ($3.13M), Armistice Capital LLC ($1.81M), Pivotal bioVenture Partners Investment Advisor LLC ($1.22M), and Dauntless Investment Group LLC ($743K).Learn more on IOBT's institutional investors. What percentage of IO Biotech stock is owned by institutional investors? 54.76% of IO Biotech stock is owned by institutional investors. Learn more on IOBT's institutional investor holdings. Which institutional investors have been buying IO Biotech stock? Of the 13 institutional investors that purchased IO Biotech stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Vivo Capital LLC ($3.16M), Armistice Capital LLC ($2.15M), Stonepine Capital Management LLC ($1.98M), PFM Health Sciences LP ($987.65K), Pivotal bioVenture Partners Investment Advisor LLC ($864.20K), Dauntless Investment Group LLC ($747.65K), and Landscape Capital Management L.L.C. ($442.20K). How much institutional buying is happening at IO Biotech? Institutional investors have bought a total of 10,790,101 shares in the last 24 months. This purchase volume represents approximately $14.93M in transactions. Which IO Biotech major shareholders have been selling company stock? The following institutional investors have sold IO Biotech stock in the last 24 months: Novo Holdings A S ($1.73M), Armistice Capital LLC ($403K), Stonepine Capital Management LLC ($309.27K), Dauntless Investment Group LLC ($66.20K), Landscape Capital Management L.L.C. ($41.96K), and Bridgeway Capital Management LLC ($25.62K). How much institutional selling is happening at IO Biotech? Institutional investors have sold a total of 2,579,865 shares in the last 24 months. This volume of shares sold represents approximately $3.25M in transactions. Related Companies Cartesian Therapeutics Institutional Ownership Immutep Institutional Ownership Aura Biosciences Institutional Ownership Canopy Growth Institutional Ownership 2seventy bio Institutional Ownership iTeos Therapeutics Institutional Ownership Terns Pharmaceuticals Institutional Ownership Monte Rosa Therapeutics Institutional Ownership Lifecore Biomedical Institutional Ownership Allogene Therapeutics Institutional Ownership This page (NASDAQ:IOBT) was last updated on 5/20/2025 by MarketBeat.com Staff From Our PartnersThe DOJ Just Said Your Money Isn’t YoursWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTrump’s treachery A shocking bill has been put before the House of Representatives… Representative Brandon Gill wants Preside...Porter & Company | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredAI Firm Enters America's Largest Medicaid MarketNew York's $95B system just approved a new AI healthcare platform. Here's what to know. A major shift in U....i2i Marketing Group, LLC | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IO Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IO Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy IOBT Stock Free IOBT Stock Alerts